Sevelamer hydrochloride versus calcium salts as phosphate binder in chronic kidney disease: A systematic review

被引:0
|
作者
Navaneethan, SD
Chaukiyal, P
Craig, J
Strippoli, GFM
机构
[1] Unity Hlth Syst, Rochester, NY USA
[2] Cochrane Renal Grp, Sydney, NSW, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
115
引用
收藏
页码:A47 / A47
页数:1
相关论文
共 50 条
  • [21] Phosphate binders in chronic kidney disease: a systematic review of recent data
    Floege, Juergen
    JOURNAL OF NEPHROLOGY, 2016, 29 (03) : 329 - 340
  • [22] The control of hyperphosphatemia in chronic kidney disease: Which phosphate binder?
    Ketteler, Markus
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2009, 32 (02): : 95 - 100
  • [23] The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats
    Cozzolino, M
    Dusso, AS
    Liapis, H
    Finch, J
    Lu, Y
    Burke, SK
    Slatopolsky, E
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (09): : 2299 - 2308
  • [24] An international economic evaluation of sevelamer hydrochloride versus calcium-based phosphate binders in patients new to dialysis
    Taylor, M. J.
    Chaplin, S.
    Elgazzar, H.
    VALUE IN HEALTH, 2007, 10 (06) : A317 - A317
  • [25] Ten-Year Experience with Sevelamer and Calcium Salts as Phosphate Binders
    Raggi, Paolo
    Vukicevic, Slobodan
    Moyses, Rosa Maria
    Wesseling, Katherine
    Spiegel, David M.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 : S31 - S40
  • [26] Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis
    Chun-Juan Zhai
    Xiao-Wei Yang
    Jing Sun
    Rong Wang
    International Urology and Nephrology, 2015, 47 : 527 - 535
  • [27] Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis
    Zhai, Chun-Juan
    Yang, Xiao-Wei
    Sun, Jing
    Wang, Rong
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (03) : 527 - 535
  • [28] The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis
    Habbous, Steven
    Przech, Sebastian
    Acedillo, Rey
    Sarma, Sisira
    Garg, Amit X.
    Martin, Janet
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (01) : 111 - 125
  • [29] Short-term efficacy of sevelamer versus calcium acetate in patients with chronic kidney disease stage 3–4
    Ashima Gulati
    Vijesh Sridhar
    Tathagata Bose
    Pankaj Hari
    Arvind Bagga
    International Urology and Nephrology, 2010, 42 : 1055 - 1062
  • [30] Renal mineral handling in normal rats treated with sevelamer hydrochloride (Renagel®), a noncalcemic phosphate binder
    Nagano, N
    Miyata, S
    Obana, S
    Eto, N
    Fukushima, N
    Burke, SK
    Wada, M
    NEPHRON, 2001, 89 (03): : 321 - 328